Table 1.

Clinical characteristics

	All	Amyloid PET	CSF	FDG PET	MRI
N	1395	743	1013	1060	1387
Visit ≥ 2 (N(%))	-	691(93.0)	633(62.5)	739(69.7)	1386(99.9)
Age, years (Mean(SD))	73.62 (7.10)	72.35 (7.22)	73.11 (7.26)	73.16 (7.16)	73.60 (7.11)
Sex, male (N(%))	768 (55.1)	392 (52.8)	556 (54.9)	593 (55.9)	764 (55.1)
Education, years (Mean(SD))	15.99 (2.81)	16.30 (2.63)	16.09 (2.75)	16.11 (2.76)	15.99 (2.82)
APOE □4 carrier (N(%))	656 (47.0)	337 (45.4)	464 (45.8)	498 (47.0)	655 (47.2)

PET positron emission tomography, CSF cerebrospinal fluid, FDG fluorodeoxyglycose, MRI magnetic resonance imaging, SD standard deviation, APOE Apolipoprotein E